spacer
home > ict > spring 2021 > accelerating towards modern clinical trials
PUBLICATIONS
International Clinical Trials

Accelerating Towards Modern Clinical Trials



Companies are racing to develop vaccines and treatments for COVID-19, prompting industry-wide urgency to initiate and expedite new trials. Yet the need to keep existing trials on track to get medicines to patients remains, and these trials are being disrupted due to the pandemic. Over 976 companies have reported interruptions to clinical trials (1).

The lengthy process of conducting clinical research has come under the spotlight and needs to be addressed. Conducting a study today is no faster than it was a decade ago, averaging six to eight years to develop a new product. Paper-based documents and departmental silos are holding trials back. There’s tremendous innovation happening in the industry, but the inefficiency of using manual processes to get advanced therapies to market has been exposed.

The industry is rapidly modernising its systems and processes to improve collaboration across stakeholders and run faster studies. Sponsors, CROs, and sites are looking for simpler ways to share information and make it easier for patients to participate in new trials, from enrolment to treatment.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the Author

Rik van Mol is a Senior Executive at Veeva Systems with over 20 years of experience in both management consulting and cloud software in the life science/pharmaceutical sector. His experience has been built in assisting clients through complex transformation programmes across the life science value chain for most of the world’s largest companies. Rik is a recognised thought leader in the life science industry with deep expertise in architecting, launching, and implementing innovative and industry-leading strategies and solutions.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Premier Research Deepens Support for Oncology Sponsors By Expanding Oncology Leadership Team

As the number of next-generation oncology therapies in the clinical trial pipeline surges, Premier Research today announced three new oncology leadership team hires to strengthen the company’s expertise in the fast-growing areas of cell and gene therapies and immuno-oncology.
More info >>

White Papers

Key to Outsourcing Method Development and Validation A Pragmatic Approach

RSSL

In an industry that is seeing an increasing level of work being outsourced, the Contract Research Organisation (CRO) of choice needs to have proven experience in both the pragmatism and flexibility of the method developer’s mind set and a regulatory background in validation.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement